CONVSGTBP• 6 Months (Normalized)
CON vs GTBP (Concentra Group Holdings Parent Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Apr 8 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CON Performance $36.21
+65.27%
Concentra Group Holdings Parent Inc.
Normalized Baseline0.00%
GTBP Performance $6.16
+1420.99%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-1355.72 pts
GTBP outperforming by 1355.72 percentage points
CONGTBP
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CON GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | CON Price | CON Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $36.21 | +65.27% | $6.16 | +1420.99% | -1355.72% |
| Oct 02, 2026 | $35.65 | +62.71% | $6.10 | +1406.17% | -1343.46% |
| Sep 30, 2026 | $35.08 | +60.11% | $- | - | |
| Sep 29, 2026 | $35.34 | +61.30% | $6.88 | +1597.53% | -1536.23% |
| Sep 28, 2026 | $35.36 | +61.39% | $6.80 | +1579.01% | -1517.62% |
| Sep 25, 2026 | $35.01 | +59.79% | $6.89 | +1601.23% | -1541.44% |
| Sep 24, 2026 | $34.62 | +58.01% | $6.83 | +1586.42% | -1528.41% |
| Sep 23, 2026 | $34.79 | +58.79% | $7.10 | +1653.09% | -1594.30% |
| Sep 22, 2026 | $34.88 | +59.20% | $- | - | |
| Sep 21, 2026 | $34.77 | +58.69% | $7.18 | +1672.84% | -1614.15% |
| Sep 18, 2026 | $35.47 | +61.89% | $7.16 | +1667.90% | -1606.01% |
| Sep 17, 2026 | $35.53 | +62.16% | $7.49 | +1749.38% | -1687.22% |
| Sep 16, 2026 | $36.37 | +66.00% | $7.81 | +1828.40% | -1762.40% |
| Sep 15, 2026 | $35.62 | +62.57% | $9.00 | +2122.22% | -2059.65% |
| Sep 14, 2026 | $35.81 | +63.44% | $11.63 | +2771.60% | -2708.16% |
Page 1 of 9